487 related articles for article (PubMed ID: 17682532)
1. [Isolation frequency and spectrum of sensitivity to antifungal preparations of vulvovaginal candidiasis pathogens].
Skliar TV; Krysenko AV; Sirokvasha EA; Vinnikov AI
Mikrobiol Z; 2007; 69(3):57-62. PubMed ID: 17682532
[TBL] [Abstract][Full Text] [Related]
2. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
Fan SR; Liu XP; Li JW
J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, species distribution and antifungal sensitivity of vaginal yeasts in infertile women.
Verghese S; Padmaja P; Asha M; Elizabeth SJ; Anitha A; Kundavi KM; Jayanthi N; Varma T
Indian J Pathol Microbiol; 2001 Jul; 44(3):313-4. PubMed ID: 12024920
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women.
Ozcan SK; Budak F; Yucesoy G; Susever S; Willke A
APMIS; 2006 Feb; 114(2):139-45. PubMed ID: 16519751
[TBL] [Abstract][Full Text] [Related]
6. Increased incidence of vulvovaginal candidiasis caused by Candida glabrata in Jordan.
Abu-Elteen KH
Jpn J Infect Dis; 2001 Jun; 54(3):103-7. PubMed ID: 11544399
[TBL] [Abstract][Full Text] [Related]
7. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.
Liu XP; Fan SR; Peng YT; Zhang HP
J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
Choukri F; Benderdouche M; Sednaoui P
J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents].
García Heredia M; García SD; Copolillo EF; Cora Eliseth M; Barata AD; Vay CA; de Torres RA; Tiraboschi N; Famiglietti AM
Rev Argent Microbiol; 2006; 38(1):9-12. PubMed ID: 16784126
[TBL] [Abstract][Full Text] [Related]
10. Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007.
Asticcioli S; Sacco L; Daturi R; Matti C; Nucleo E; Zara F; Pagani L
New Microbiol; 2009 Apr; 32(2):199-204. PubMed ID: 19579700
[TBL] [Abstract][Full Text] [Related]
11. [Vulvovaginal candidiasis and sensitivity of pathogens to antimycotics].
Sojáková M; Liptajová D; Simoncicová M; Borovský M; Subík J
Ceska Gynekol; 2003 Jan; 68(1):24-9. PubMed ID: 12708111
[TBL] [Abstract][Full Text] [Related]
12. Vulvovaginal candidiasis in a Flemish patient population.
De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of yeasts implicated in vulvovaginal candidosis in Irish women.
al-Rawi N; Kavanagh K
Br J Biomed Sci; 1999; 56(2):99-104. PubMed ID: 10695049
[TBL] [Abstract][Full Text] [Related]
14. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents.
Redondo-Lopez V; Lynch M; Schmitt C; Cook R; Sobel JD
Obstet Gynecol; 1990 Oct; 76(4):651-5. PubMed ID: 2216197
[TBL] [Abstract][Full Text] [Related]
15. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data.
Samonis G; Kofteridis DP; Saloustros E; Giannopoulou KP; Ntziora F; Christidou A; Maraki S; Falagas ME
Scand J Infect Dis; 2008; 40(5):414-9. PubMed ID: 18418802
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic and clinical characteristics of mycotic vaginitis caused by Candida glabrata (Torulopsis glabrata)].
Pawlik B; Liber Z; Warzyńska R
Med Dosw Mikrobiol; 1989; 41(3-4):206-14. PubMed ID: 2701236
[TBL] [Abstract][Full Text] [Related]
17. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana.
Adjapong G; Hale M; Garrill A
Med Mycol; 2017 Aug; 55(6):686-689. PubMed ID: 27838642
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and in vitro activity of antimycotics against candidal vaginal/skin/nail infections in Singapore.
Kwok YK; Tay YK; Goh CL; Kamarudin A; Koh MT; Seow CS
Int J Dermatol; 1998 Feb; 37(2):145-9. PubMed ID: 9542677
[TBL] [Abstract][Full Text] [Related]
19. Soaps and germicides as adjunct topical antimycotic agents on candida species implicated in vulvovaginal candidasis.
Ogunshe AA; Omotoso OA; Akindele TM
East Afr J Public Health; 2011 Jun; 8(2):112-8. PubMed ID: 22066296
[TBL] [Abstract][Full Text] [Related]
20. Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis.
Liu XP; Fan SR; Bai FY; Li J; Liao QP
Mycoses; 2009 Jan; 52(1):24-8. PubMed ID: 18498300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
